Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
2 Articles
2 Articles
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer ove…
A study conducted by researchers at Washington University School of Medicine in St. Louis suggests that GLP-1 medications, widely used for weight loss and type 2 diabetes management, may significantly reduce the risks of addiction and overdose among users. The research analyzed data from over 600,000 veterans in the United States. The investigation involved 606,434 veterans with type 2 diabetes, divided into two groups: one without substance use…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
